• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>AstraZeneca PLC ADR

AstraZeneca PLC ADR

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. AstraZeneca's Flu-Vaccine Spray Fails

    AstraZeneca's Flu-Vaccine Spray Fails

  2. AstraZeneca Agrees Anesthetics Portfolio Rights Pact With Aspen Global

    AstraZeneca Agrees Anesthetics Portfolio Rights Pact With Aspen Global

  3. Sosei Appoints Peter Bains as CEO

    Sosei Appoints Peter Bains as CEO

  4. Foundation Medicine and AstraZeneca Enter Strategic Collaboration for Lynparza Companion Diagnostic Assay

    Foundation Medicine and AstraZeneca Enter Strategic Collaboration for Lynparza Companion Diagnostic Assay

  5. AstraZeneca Presents Findings from Two Pooled Analyses at the 76th Scientific Sessions of the American Diabetes Association Evaluating Dapagliflozin in Type 2 Diabetes Patients with Renal Impairment ...

    AstraZeneca Presents Findings from Two Pooled Analyses at the 76th Scientific Sessions of the American Diabetes Association Evaluating Dapagliflozin in Type 2 Diabetes Patients with Renal Impairment and in Combination with Potassium-Sparing Agents

  6. AstraZeneca Presents New Data from Multiple Studies on the Effect of BYDUREON on Glucose Fluctuations in Patients with Type 2 Diabetes

    AstraZeneca Presents New Data from Multiple Studies on the Effect of BYDUREON on Glucose Fluctuations in Patients with Type 2 Diabetes

  7. Global Hairy Cell Leukemia Pipeline Review, H1 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: AstraZeneca , MedImmune, Novartis - Research and Markets

    Global Hairy Cell Leukemia Pipeline Review, H1 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: AstraZeneca , MedImmune, Novartis - Research and Markets

  8. AstraZeneca Licenses Zurampic to Grunenthal in Europe, Latin America

    AstraZeneca Licenses Zurampic to Grunenthal in Europe, Latin America

  9. AstraZeneca Completes US Licensing Pact with Ironwood Pharmaceuticals

    AstraZeneca Completes US Licensing Pact with Ironwood Pharmaceuticals

  10. Technavio Announces Top Ten Vendors in the Global Chronic Lymphocytic Leukemia Market from 2016 to 2020

    Technavio Announces Top Ten Vendors in the Global Chronic Lymphocytic Leukemia Market from 2016 to 2020

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.